Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid IV versus IV plus local administration for pertrochanteric hip fracture surgery
2022-003163-21Phase 3Active
- Sponsor
- Coral Sánchez Pérez
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intertrochanteric fracture and hip fracture comparing Intravenous tranexamic acid plus local tranexamic acid with Intravenous tranexamic acid plus local placebo (2 arms). Primary endpoint: Reduction of blood loss. Started Mar 2023; status: active.
02
Drugs
tranexamic acid
03
Conditions
intertrochanteric fracturehip fracture
Beyond the preview
Go deeper on 2022-003163-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003163-21.